• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Comprehensive Overview of 2-Pyrimidinemethanol, 4-bromo- (CAS No. 1378694-41-7): Properties, Applications, and Industry Insights

2-Pyrimidinemethanol, 4-bromo- (CAS No. 1378694-41-7) is a specialized organic compound that has garnered significant attention in pharmaceutical and agrochemical research. This brominated pyrimidine derivative is characterized by its unique molecular structure, combining a pyrimidine ring with a hydroxymethyl functional group at the 2-position and a bromo substituent at the 4-position. Such structural features make it a valuable intermediate in the synthesis of more complex molecules, particularly in drug discovery and material science applications.

The growing interest in heterocyclic compounds like 4-bromo-2-pyrimidinemethanol stems from their versatility in medicinal chemistry. Researchers are increasingly exploring its potential as a building block for kinase inhibitors, which are pivotal in targeted cancer therapies. Recent studies highlight its role in modulating enzymatic activity, aligning with the industry's focus on precision medicine and personalized therapeutics. This connection to cutting-edge medical trends enhances its relevance in current scientific discourse.

From a synthetic chemistry perspective, CAS 1378694-41-7 offers distinct advantages due to its reactivity profile. The bromine atom facilitates cross-coupling reactions, such as Suzuki-Miyaura or Buchwald-Hartwig couplings, enabling efficient carbon-carbon bond formation. Meanwhile, the hydroxymethyl group provides an anchor point for further derivatization, making it a flexible scaffold for combinatorial chemistry. These attributes answer frequent search queries like "pyrimidine derivatives in drug design" or "bromo-substituted heterocycles synthetic applications".

Industrial applications of 2-Pyrimidinemethanol, 4-bromo- extend beyond pharmaceuticals. Its incorporation into liquid crystal materials and organic electronic components addresses the surging demand for advanced functional materials. With the rise of OLED technology and flexible displays, this compound's ability to influence molecular packing and charge transport properties positions it as a candidate for next-generation optoelectronic devices—a topic frequently searched in materials science forums.

Quality control and analytical characterization of 1378694-41-7 involve advanced techniques like HPLC purity analysis, mass spectrometry, and NMR spectroscopy. These methods ensure batch-to-batch consistency, particularly important for researchers investigating structure-activity relationships. The compound's stability under various storage conditions (often queried as "pyrimidine derivative storage guidelines") has been documented, with recommendations for anhydrous environments to preserve reactivity.

Environmental and regulatory considerations surrounding 4-bromo-2-pyrimidinemethanol reflect broader industry shifts toward green chemistry. Recent publications explore solvent-free synthesis routes and catalytic systems to minimize waste generation—addressing search trends like "sustainable heterocycle synthesis". The compound's biodegradability profile and ecotoxicological data remain active research areas, particularly for agrochemical applications where environmental persistence is scrutinized.

Market intelligence indicates steady growth in demand for CAS 1378694-41-7, driven by expanding contract research organizations and generic drug development pipelines. Procurement specialists often search for "reliable 4-bromo-2-pyrimidinemethanol suppliers" or "bulk pyrimidine derivatives pricing", reflecting commercial interest. The compound's global availability through specialty chemical distributors supports its accessibility for diverse research programs.

Future research directions for this compound may explore its utility in proteolysis targeting chimeras (PROTACs)—a hot topic in drug discovery circles. Its potential as a linker component in bifunctional molecules could unlock novel therapeutic modalities. Such applications would build upon existing knowledge while answering emerging search queries about "pyrimidine scaffolds in targeted protein degradation", demonstrating the compound's evolving scientific significance.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)